Discover the complete record of transactions filed by Sabus Steve M, Directeur Commercial. Insider active across 1 company, notably Turning Point Therapeutics, Inc.. Cumulatively, 1 filings have been recorded. Activity tracked since 31 May 2022. The latest transaction was disclosed on 31 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Steve M. Sabus is the Chief Commercial Officer at Turning Point Therapeutics, Inc. He is responsible for the company's commercial strategy, including sales development and partnerships. His role is essential in maximizing market opportunities and strengthening the company's position in the biotechnology sector. Steve plays a key role in expanding Turning Point's operations.